What researchers published on Tripla negatív emlőrák
19 708 papers, newest first.
Showing 40 of 19 708
Fusobacterium nucleatum-mediated tryptophan metabolic reprogramming facilitates immunosuppression and metastasis in triple-negative breast cancer.Genes & diseases
Szisztematikus áttekintésPeripheral absolute lymphocyte count and survival of patients with triple-negative breast cancer: a meta-analysis.Frontiers in oncology
ÁttekintésEfficacy of adding neoadjuvant pembrolizumab to standard chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis of real-world studies.Pakistan journal of medical sciences
Zinc-Coordinated Nanoplatform Overcomes Chemoimmunotherapy Resistance via Dual Blockade of Programmed Death-ligand 1 and Tryptophan Metabolism in Triple-negative Breast Cancer.Acta biomaterialia
KLK11 Overexpression Inhibits YAP-Associated Signaling and Suppresses Malignant Phenotypes in Triple-Negative Breast Cancer Cells.Breast cancer (Dove Medical Press)
Membrane-Context Screening Identifies a Functionally Active Peptide for Targeted Nanodelivery in Triple-Negative Breast Cancer.ACS nano
EsetismertetésMetastatic Triple-Negative Male Breast Carcinoma of Occult Primary With Axillary Nodal and Cutaneous Metastases.World journal of oncology
ÁttekintésDual-target CAR-T cells in triple-negative breast cancer: recent advances and translational challenges.Frontiers in medicine
Association Between Cancer Stage and Parenting Self-Efficacy in Breast Cancer Survivors: A Survey of a Triple-Negative Breast Cancer Community.Journal of Korean medical science
Targeting SOST-LRRC15 axis impairs triple-negative breast cancer progression by regulating WNT signaling and EMT.iScience
RGDfC-functionalized gold nanoclusters versus the clinical radiosensitizer sodium glycididazole in triple-negative breast cancer radiotherapy.PloS one
Esetismertetés[Leptomeningeal Carcinomatosis Developing during Neoadjuvant Immunochemotherapy for Occult Breast Cancer-A Case Report].Gan to kagaku ryoho. Cancer & chemotherapy
ÁttekintésPersonalizing Adjuvant Radiotherapy After Complete Response in Locally Advanced Triple-Negative Breast Cancer: Exploring the Potential Role of BRCA Status.Clinical breast cancer
Mid-treatment radiologic response as an early predictor of pathologic response in TNBC in the era of pembrolizumab.Breast cancer research : BCR
Phase-Space Distance Between Stationary States Modulates Phenotypic Plasticity in Breast Cancer.Bulletin of mathematical biology
Tumor-targeted transferrin nanoassemblies delivering olaparib and curcumin for combating BCRP-mediated resistance in triple-negative breast cancer.Biomaterials science
EsetismertetésPembrolizumab-Associated Secondary Adrenal Insufficiency Due to Isolated Adrenocorticotropic Hormone (ACTH) Deficiency Presenting as Recurrent Multisystem Decompensation in Triple-Negative Breast Cancer.Cureus
Tertiary lymphoid structures and the systemic immune-inflammation index define distinct pathologic response phenotypes in triple-negative breast cancer receiving neoadjuvant chemoimmunotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
MRI Radiomics-Based Nomogram Integrating Skeletal Muscle Assessment for Predicting Pathologic Complete Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.Diagnostics (Basel, Switzerland)
β-galactosidase-activatable photosensitization for selective, light-amplified pyroptosis therapy of triple-negative breast Cancer cells.Bioorganic chemistry
In Vitro Models of Triple-Negative Breast Cancer of Sub-Saharan African Ancestry Suggest BLM-Centred DNA Damage Repair Dependency and Pevonedistat Sensitivity.International journal of molecular sciences
ÁttekintésThe Role of Hypoxia-Inducible Factors (HIFs) in Triple-Negative Breast Cancer Radiation Resistance.International journal of molecular sciences
Leptin-Driven Distinct Transcriptional Reprogramming in Triple-Negative Breast Cancer: Implications for Racial Disparities.International journal of molecular sciences
MetaanalízisSurvival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.Breast cancer research and treatment
Promoter hypomethylation associated with elevated TRIM33 expression in triple-negative breast cancer patients.Frontiers in oncology
Early Change in the Pan-Immune-Inflammation Value During Neoadjuvant Chemotherapy Is Associated with Pathological Complete Response in HER2-Positive and Triple-Negative Breast Cancer: A Single-Centre Study with Temporal Validation.Journal of clinical medicine
ÁttekintésRecent Advances in Mitochondria-Targeted Nanoparticle Photodynamic Therapy for Triple-Negative Breast Cancer.International journal of molecular sciences
RETRACTED: Kim et al. Autocrine Motility Factor and Its Peptide Derivative Inhibit Triple-Negative Breast Cancer by Regulating Wound Repair, Survival, and Drug Efflux. Int. J. Mol. Sci. 2024, 25, 11714.International journal of molecular sciences
Updated results from ASCENT-J02, a study of sacituzumab govitecan in Japanese participants with metastatic triple-negative breast cancer.International journal of clinical oncology
ÁttekintésSQSTM1/p62 and Mitochondrial Stress in Triple-Negative Breast Cancer: A Critical Pathology Perspective.Cancers
Targeting AP1S1 modulates the unfolded protein response and cell cycle and sensitizes triple-negative breast cancer to erlotinib.Tissue & cell
Matrix-Associated Gene Expression and Annotated Tumor-Stroma Composition of Transcriptomically Defined Cold Regions in Triple-Negative Breast Cancer.Cancers
Oral 25-Hydroxycholesterol Suppresses 4T1 Tumour Growth in an Immune-Context-Associated Manner.International journal of molecular sciences
Neoadjuvant Versus Adjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer: A National Cancer Database Study.Cancers
ÁttekintésCirculating Non-Coding RNAs as Liquid Biopsy Biomarkers for Early Detection of Triple-Negative Breast Cancer: From Diagnostic Performance to Clinical Translation.Diagnostics (Basel, Switzerland)
Cell-Cell Communication Network Analysis of Tertiary Lymphoid Structures in Triple-Negative Breast Cancer.Current cancer drug targets
CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell-suppressive function in triple-negative breast cancer and other immunoregulatory settings.Journal of immunology (Baltimore, Md. : 1950)
Dual-Targeted Nanoparticle Chimeras Induce Bioenergetic Crisis by Coupling Lipid Droplet Degradation with Nicotinamide Adenine Dinucleotide Reduction in Triple-Negative Breast Cancer.Acta biomaterialia
Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor.Pharmacological research
FOXA1 expression and survival outcomes in triple-negative breast cancer: A retrospective cohort study.PloS one